Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Oct;72(10):1431–1439. doi: 10.1002/acr.24328

Table 2.

Annual Rates of Cardiovascular Disease (combined Myocardial Infarction or Stroke), and Myocardial Infarction and Stroke separately in Systemic Lupus Erythematosus (SLE), Diabetes Mellitus (DM), and General Population (Non-SLE/Non-DM) Medicaid patients (2007–2010)

Number of Patients Mean Age at Event, years (SD) Number of Events Person-years, mean (SD) IR* (95% CI) IRR**a (Reference: DM) (95%CI) IRR**b (Reference: General population) (95%CI)
Cardiovascular Disease
General Population 160,848 52.56 (8.78) 657 1.73 (1.14) 2.36 (2.19–2.55) 0.34 (0.33–0.34) 1.0 (ref.)
DM 80,424 49.38 (9.92) 1060 1.86 (1.11) 7.07 (6.66–7.51) 1.0 (ref.) 2.98 (2.90–3.06)
SLE 40,212 45.04 (12.49) 672 1.86 (1.11) 8.99 (8.34–9.70) 1.27 (1.23–1.30) 3.78 (3.67–3.89)
Myocardial Infarction
General Population 160,848 53.40 (8.24) 233 1.73 (1.14) 0.83 (0.73–0.94) 0.28 (0.27–0.29) 1.0 (ref.)
DM 80,424 49.87 (9.40) 454 1.87 (1.11) 3.01 (2.75–3.30) 1.0 (ref.) 3.60 (3.49–3.71)
SLE 40,212 46.80 (12.16) 243 1.87 (1.11) 3.23 (2.85–3.66) 1.07 (1.04–1.10) 3.85 (3.72–3.99)
Stroke
General Population 160,848 52.15 (8.99) 433 1.73 (1.14) 1.55 (1.41–1.70) 0.37 (0.36–0.38) 1.0 (ref.)
DM 80,424 49.16 (10.30) 642 1.87 (1.11) 4.27 (3.95–4.61) 1.0 (ref.) 2.74 (2.66–2.82)
SLE 40,212 44.14 (12.59) 448 1.87 (1.11) 5.97 (5.44–6.55) 1.40 (1.36–1.44) 3.82 (3.71–3.94)

SLE= Systemic Lupus Erythematosus, DM=Diabetes Mellitus, SD= Standard Deviation

*

IR = incidence rate, annual CVD event rate per 1,000 person years

**

IRR= incidence rate ratio

a

Diabetes Mellitus used as the reference group;

b

General Population used as the reference group.